Context Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.7% | -21.7% | -20.4% |
| FY2022 | -42.7% | -42.7% | -39.1% |
| FY2023 | -201.9% | -201.9% | -149.2% |
| FY2024 | -28.1% | -28.1% | -27.2% |
| FY2025 | -59.7% | -59.7% | -52.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.7% | -21.7% | -20.4% |
| FY2022 | -42.7% | -42.7% | -39.1% |
| FY2023 | -201.9% | -201.9% | -149.2% |
| FY2024 | -28.1% | -28.1% | -27.2% |
| FY2025 | -59.7% | -59.7% | -52.7% |